Clinical Trial Update: Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluates a new design of the iodine-125 seed to maintain its intended position when implanted in the prostate. The study relates to prostate ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Iodine-125 seed (Iodine-125 seed radiation source)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED